Shares of Tesla have hit new highs on optimism about the company’s self-driving taxis. But experts say Tesla is far behind Waymo, which has a big head start. By Jack Ewing Reporting from Austin, Texas ...

As Tesla announces sales that are down 9 percent over last year, a new EV king is crowned. BYD sold over 2 million battery-powered vehicles last year, making it the largest EV manufacturer globally.

Elon Musk's Tesla has had a tough year and faced intensifying competition from Chinese and European rivals. Annual sales figures for 2025 show Tesla has lost its crown as the world's top electric ...

In a related news, Elon Musk recently said that he plans to be Tesla CEO in the next five years. Musk made a virtual appearance on the Qatar Economic Forum recently where he was asked “Do you see ...

Chinese auto giant BYD surpassed Tesla to become the world’s top electric-vehicle seller in 2025, according to new data released by the two companies. The Chinese automaker has come a long way since ...

Ce dimanche soir contre La Rochelle (60-14), Antoine Dupont a été tout bonnement exceptionnel. Parmi les actions qui ont contribué à sa masterclass, on retrouve notamment son essai inscrit, en ...

Le RCT s’est imposé avec le bonus offensif contre l’Usap (31-16), ce dimanche 28 décembre, à domicile. Le Lorientais Gaël Dréan a inscrit le cinquième essai des Rouge et Noir. Gaël Dréan a inscrit son ...

An SEC filing said the gift was made in connection with "year-end tax planning." Musk has previously told investors he needs more voting shares to build a "robot army." Forget champagne — Elon Musk ...

L'ancien best-seller peut-il revenir au top après son restylage ? La Tesla Model Y est un best-seller. Pour le moment. Car ce qui semblait autrefois être un succès garanti montre récemment des signes ...

l'essentiel Pour son grand retour après neuf mois de convalescence (rupture des ligaments croisés), Antoine Dupont a littéralement surclassé La Rochelle (60-14) ce dimanche 28 décembre au Stadium de ...

05:39 L'Epcoritamab de Genmab Améliore la Survie Sans Progression chez les Patients Atteints de Lymphome, Selon les Données de Phase 3 MT 16/01 Genmab A/S annonce les résultats principaux de l'étude ...